Onconetix Stock Forecast - Accumulation Distribution
| ONCO Stock | USD 0.80 0.29 26.61% |
Onconetix Stock Forecast is based on your current time horizon. Although Onconetix's naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Onconetix's systematic risk associated with finding meaningful patterns of Onconetix fundamentals over time.
Onconetix |
| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 8701.53 | 6349.01 |
| Check Onconetix Volatility | Backtest Onconetix | Trend Details |
Onconetix Trading Date Momentum
| On October 09 2024 Onconetix was traded for 5.00 at the closing time. The top price for the day was 5.17 and the lowest listed price was 4.91 . The trading volume for the day was 20 K. The trading history from October 9, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 1.96% . The trading delta at closing time against the current closing price is 14.31% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Onconetix to competition |
Other Forecasting Options for Onconetix
For every potential investor in Onconetix, whether a beginner or expert, Onconetix's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Onconetix Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Onconetix. Basic forecasting techniques help filter out the noise by identifying Onconetix's price trends.Onconetix Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Onconetix stock to make a market-neutral strategy. Peer analysis of Onconetix could also be used in its relative valuation, which is a method of valuing Onconetix by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Onconetix Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Onconetix's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Onconetix's current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Onconetix Market Strength Events
Market strength indicators help investors to evaluate how Onconetix stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Onconetix shares will generate the highest return on investment. By undertsting and applying Onconetix stock market strength indicators, traders can identify Onconetix entry and exit signals to maximize returns.
| Accumulation Distribution | 68887.62 | |||
| Daily Balance Of Power | (1.00) | |||
| Rate Of Daily Change | 0.73 | |||
| Day Median Price | 0.94 | |||
| Day Typical Price | 0.89 | |||
| Price Action Indicator | (0.28) | |||
| Period Momentum Indicator | (0.29) | |||
| Relative Strength Index | 25.29 |
Onconetix Risk Indicators
The analysis of Onconetix's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Onconetix's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting onconetix stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 6.99 | |||
| Standard Deviation | 13.12 | |||
| Variance | 172.04 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Pair Trading with Onconetix
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Onconetix position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Onconetix will appreciate offsetting losses from the drop in the long position's value.Moving together with Onconetix Stock
| 0.63 | A | Agilent Technologies | PairCorr |
| 0.7 | ME | 23Andme Holding | PairCorr |
| 0.74 | VALN | Valneva SE ADR | PairCorr |
| 0.8 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
Moving against Onconetix Stock
| 0.72 | MDGL | Madrigal Pharmaceuticals | PairCorr |
| 0.61 | RNXT | RenovoRx | PairCorr |
| 0.38 | NXGLW | NexGel Warrant | PairCorr |
| 0.37 | KEP | Korea Electric Power | PairCorr |
The ability to find closely correlated positions to Onconetix could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Onconetix when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Onconetix - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Onconetix to buy it.
The correlation of Onconetix is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Onconetix moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Onconetix moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Onconetix can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Historical Fundamental Analysis of Onconetix to cross-verify your projections. To learn how to invest in Onconetix Stock, please use our How to Invest in Onconetix guide.You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Onconetix. If investors know Onconetix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Onconetix listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (109.20) | Revenue Per Share 2.892 | Return On Assets (0.22) | Return On Equity (17.58) |
The market value of Onconetix is measured differently than its book value, which is the value of Onconetix that is recorded on the company's balance sheet. Investors also form their own opinion of Onconetix's value that differs from its market value or its book value, called intrinsic value, which is Onconetix's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Onconetix's market value can be influenced by many factors that don't directly affect Onconetix's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Onconetix's value and its price as these two are different measures arrived at by different means. Investors typically determine if Onconetix is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Onconetix's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.